DUBLIN , Sept. 5, 2022 /PRNewswire/ -- The "Global Blood Warmers Market Size, Share & Trends Analysis Report by Product (Portable, Non-portable Blood Warmers), by End-use (Hospitals/Clinic, Ambulatory Services, Defense Forces, Rescue Forces), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The global blood warmers market size is anticipated to reach USD 2.0 billion by 2030. The market is expected to expand at a CAGR of 8.4% from 2022 to 2030. Rising incidences of road accidents, mishaps and other injuries, rising burden of hypothermia cases along with growing demand for blood warmers from ambulatory services and military/defense sectors, operating in extreme temperature environments are expected to propel the market demand for such devices over the forecast period. Over the recent past, the COVID-19 pandemic has been associated with surges in hospitalization globally, this is expected to have a positive impact on the market. The demand for infusion therapy surged significantly during this period. This is one of the key factors driving up demand for blood warmer devices, which are used to raise fluids to body temperature, speed up patient recovery, and reduce the danger of transfusion shock. Moreover, various manufacturers are adopting strategies such as mergers and acquisitions, partnerships, and product launches to strengthen their foothold in the market. For instance, in December 2020 , Danish MedTech Company MEQU released the Power Pack, a new battery for its M Warmer System, a compact blood and IV fluid-warming systems. The system is commonly used in prehospital emergency settings. Such product launches are expected to propel the market over the forecast period. Blood Warmers Market Report Highlights
Based on product, non-portable blood warmers segment held the largest market share of 55.47% in 2021. The increasing rate of hospitalization rising aging population, and improving financing for healthcare infrastructure in developing economies are all likely to propel this segment growth.
In end-use scope, the hospital-based segment dominated the market with a share of 65.45% in 2021. Blood warmers are commonly employed in hospitals because they can heat a larger volume of blood or IV solutions while also being more affordable & easier to maintain.
North America dominated the blood warmers market and accounted for the highest revenue share of 40.7% in 2021, owing to the increase in the number of surgical procedures/hospital visits, presence of well-established healthcare infrastructure, and favorable reimbursement in the healthcare sector.
Key Topics Covered: Chapter 1 Methodology and Scope Chapter 2 Executive Summary Chapter 3 Blood Warmers Market Variables, Trends & Scope 3.1 Market Lineage Outlook 3.1.1 Parent Market Outlook 3.1.2 Ancillary Market Outlook 3.2 Penetration & Growth Prospect Mapping 3.3 User Perspective Analysis 3.3.1 Consumer Behavior Analysis 3.3.2 Market Influencer Analysis 3.4 List Of Key End-Users 3.5 Market Dynamics 3.5.1 Market Driver Analysis 3.5.1.1 Increasing number of surgeries and trauma cases 3.5.1.2 Growing demand for blood warmers from ambulatory services and military/defense sectors 3.5.1.3 Increasing demand for portable blood/iv fluid warmers 3.5.2 Market Restraints Analysis 3.5.2.1 Low Market Penetration In Emerging Economies Due To High Cost 3.5.2.2 Product Recalls 3.5.3 Market Opportunities Analysis 3.5.3.1 Increasing R&D Of Innovative Products 3.6 blood warmers: Market Analysis Tools 3.6.1 Industry Analysis-Porter's 3.6.2 Swot Analysis, By Pest 3.7 Impact of COVID-19 on Market & Post Pandemic Recovery Analysis Chapter 4 Blood warmers Market: Segment Analysis, By Product, 2018-2030 (USD Million) 4.1 Definition and Scope 4.2 Product Market Share Analysis, 2021 & 2030 4.3 Segment Dashboard 4.4 Global Blood Warmers Market, by Product, 2017 to 2030 4.5 Market Size & Forecasts and Trend Analysis, 2017 to 2030 4.4.1 Portable Blood Warmers 4.4.1.1 Portable Blood Warmers Market, 2018-2030 (USD Million) 4.4.2 Non-Portable Blood Warmers 4.4.2.1 Non-portable Blood Warmers market, 2018-2030 (USD Million) Chapter 5 Blood warmers Market: Segment Analysis, By End-use, 2018-2030 (USD Million) 5.1 Definition and Scope 5.2 End-use Market Share Analysis, 2021 & 2030 5.3 Segment Dashboard 5.4 Global Blood Warmers Market, by End-use, 2017 to 2030 5.5 Market Size & Forecasts and Trend Analysis, 2017 to 2030 5.5.1 Hospitals/Clinic 5.5.1.1 Hospitals/Clinic Market, 2018-2030 (USD Million) 5.5.2 Ambulatory Services 5.5.2.1 Ambulatory Services Market, 2018-2030 (USD Million) 5.5.3 Defense Forces 5.5.3.1 Defense Forces Market, 2018-2030 (USD Million) 5.5.4 Rescue Forces 5.5.4.1 Rescue forces market, 2018-2030 (USD Million) Chapter 6 Blood warmers Market: Regional Market Analysis, By Product, By End-use 2018-2030 (USD Million) Chapter 7 Blood Warmers Market-Competitive Analysis 7.1 Recent Developments & Impact Analysis, by Key Market Participants 7.2 Company Categorization 7.2.1 Innovators 7.2.2 Market Leaders 7.3 Company Profiles 7.3.1 STRYKER CORPORATION 7.3.1.1 Company overview 7.3.1.2 Financial performance 7.3.1.3 Product benchmarking 7.3.1.4 Strategic initiatives 7.3.2 BAXTER INTERNATIONAL 7.3.2.1 Company overview 7.3.2.2 Financial performance 7.3.2.3 Product benchmarking 7.3.2.4 Strategic initiatives 7.3.3 GENTHERM MEDICAL 7.3.3.1 Company overview 7.3.3.2 Financial performance 7.3.3.3 Product benchmarking 7.3.3.4 Strategic initiatives 7.3.4 BELMONT MEDICAL 7.3.4.1 Company overview 7.3.4.2 Financial performance 7.3.4.3 Product benchmarking 7.3.4.4 Strategic initiatives 7.3.5 3M 7.3.5.1 Company overview 7.3.5.2 Financial performance 7.3.5.3 Product benchmarking 7.3.5.4 Strategic initiatives 7.3.6 ICU MEDICAL 7.3.6.1 Company overview 7.3.6.2 Financial performance 7.3.6.3 Product benchmarking 7.3.6.4 Strategic initiatives 7.3.7 VYAIRE MEDICAL, INC. 7.3.7.1 Company overview 7.3.7.2 Financial performance 7.3.7.3 Product benchmarking 7.3.7.4 Strategic initiatives 7.3.8 THE SURGICAL COMPANY PTM 7.3.8.1 Company overview 7.3.8.2 Financial performance 7.3.8.3 Product benchmarking 7.3.8.4 Strategic initiatives 7.3.9 LIFE WARMER 7.3.9.1 Company overview 7.3.9.2 Financial performance 7.3.9.3 Product benchmarking 7.3.9.4 Strategic initiatives 7.3.10 MEQU 7.3.10.1 Company overview 7.3.10.2 Financial performance 7.3.10.3 Product benchmarking 7.3.10.4 Strategic initiatives 7.3.11 ESTILL MEDICAL TECHNOLOGIES, INC. 7.3.11.1 Company overview 7.3.11.2 Financial performance 7.3.11.3 Product benchmarking 7.3.11.4 Strategic initiatives 7.3.12 SMISSON-CARTLEDGE BIOMEDICAL 7.3.12.1 Company overview 7.3.12.2 Financial performance 7.3.12.3 Product benchmarking 7.3.12.4 Strategic initiatives For more information about this report visit https://www.researchandmarkets.com/r/a4fdxm
Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/the-worldwide-blood-warmers-industry-is-expected-to-reach-2-billion-by-2030-301617743.html
As we close in on the final quarter of 2022, investors are looking for an answer to one question: was June’s low the bottom for stocks, or do they have more room to fall? It’s a serious question, and there may be no easy answer. Markets are facing a series of headwinds, from the high inflation and rising interest rates that we’ve grown familiar with to an increasingly strong dollar that will put pressure on the upcoming Q3 earnings. Weighing in on current conditions from Charles Schwab, the $8 t
Nio (NYSE: NIO) reported increasing losses in its second-quarter earnings report this week, but investors are shrugging that off, sending shares soaring Friday morning. Although its profit margins have been on a downward trend, new models being launched could turn that around in the coming years. Consumer prices in China increased at a slower pace than many expected in August, and producer inflation sank to the lowest level since February 2021, reports Reuters.
Advanced Micro Devices, Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $AMD performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.Check out the ticker page here.
The S&P 500 is on again, off again all year. But investors clearly have a "buy list" of stocks they want to own when the rally looks real.
Canadian cannabis company Tilray Brands (NASDAQ: TLRY) hasn't been a great stock for shareholders over the last year, with shares down more than 70%. Part of the reason for that has been the lack of progress toward legalizing cannabis in the U.S. But Tilray has established a presence south of the Canadian border and has profitable beer and spirits businesses there. An expansion of one of those businesses had investors pushing Tilray stock 4.6% higher as of 12:40 p.m. ET Friday.
Gary Gensler had strong words for the crypto industry in a Thursday speech, telling an audience of lawyers that the "vast majority" of the nearly 10,000 existing crypto tokens are securities.
It's time to be extra picky.
A strong bearish trend defined the markets in the first half of the year; since then, the key point has been volatility. Stocks hit a bottom back in June, when the S&P 500 dropped into the 3,600s. That has proven to be a support level in the last two months, and at least one strategist believes that the market won’t be testing those lows again this year. JPMorgan's Jason Hunter believes that inflation may have peaked, and that the upcoming CPI report will provide additional evidence of that. “We
In this article, we will look at 10 stocks that Jim Cramer is talking about in September. If you want to explore more stocks that journalist investor, Jim Cramer, is talking about in September, you can also take a look at Jim Cramer is Talking About These 5 Stocks in September. Jim Cramer has acquired […]
AT&T income-hungry shareholders should have seen it coming. In April last year, a month before announcing the spinoff of its media division to shareholders in the form of shares of a 71% stake in the newly created Warner Bros. Discovery Chief Executive Officer John Stankey assured investors that “our deliberate capital-allocation plan allowed us to invest and sustain our dividend at current levels, which we believe is attractive.” AT&T’s eventual failure to raise the dividend in 2021 broke a 34-year streak and saw it booted out of the vaunted S&P 500 Dividend Aristocrats Index.
See how to gauge demand and strength in Apple, Nasdaq and other stocks on the latest list of new buys by the best mutual funds.
Investors are seeing higher growth potential for QuantumScape's battery cell technology after an interesting EV industry development.
The automaker's resilience in this economic downturn is something to be admired
Shares of AMC Entertainment (NYSE: AMC) are rising 8.7% higher at 10:13 a.m. ET on Friday following CEO Adam Aron thanking the movie theater operator's shareholders for their support as rival Cineworld (OTC: CNNW.F) filed for bankruptcy on Wednesday. It's been expected for some time that the Regal theater owner would eventually file, as the industry is still racked by low attendance, but Aron assured investors AMC is in a "very, very different situation." Although both theater operators have over $5 billion in debt, Aron maintains it was because of investors who rallied behind the stock over the past year that AMC doesn't find itself in a similar position.
CrowdStrike Holdings (NASDAQ: CRWD) was one of the more lucrative cybersecurity stocks to own on the last trading day of the week. Said note was authored by Cantor Fitzgerald's Jonathan Ruykhaver, who initiated coverage on four cybersecurity stocks after market hours on Thursday. Of the four, CrowdStrike saw the biggest price pop today.
The Facebook and Instagram owner's share price zoomed more than 4% higher on Friday, as investors bid the company up on news that it had disbanded one of its teams. Thursday afternoon, The Wall Street Journal reported that Meta had dissolved the Responsible Innovation (RI) unit at the company. This was the team that kept an eye on the ethics of its products and services, which also include messaging app WhatsApp in addition to Facebook and Instagram.
In an effort to streamline the regulation that governs how retirement accounts can be used, the IRS has proposed a change for 403(b) plans - a type of workplace retirement plan use mostly by public and non-profit employees. Employer-sponsored plans … Continue reading → The post The IRS Is Changing How Your Beneficiaries Receive Your Retirement Funds appeared first on SmartAsset Blog.
Wall Street firm BofA Securities on Friday identified seven semiconductor stocks that it believes can withstand the current market downturn.
In this article, we discuss 10 dividend stocks with over 8% yield to buy in September. You can skip our detailed analysis of top high dividend stocks, and go directly to read 5 Best Dividend Stocks with Over 8% Yield You Can Buy in September. In the current market situation, investors are looking for different […]
The leading payments processing company and an iconic consumer staple both belong in Berkshire Hathaway's investment portfolio.